University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 12 of 17
Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers
NCT02501538
Chronotropic Incompetence in Patients With HFpEF
NCT02524145
Neoadjuvant Itraconazole in Non-small Cell Lung Cancer
NCT02357836
HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
NCT02464137
Pilot Study of NeuroTriage Device in Patients with Potential Brain Injury And/or Impairment
NCT03761641
Gemfibrozil for Nicotine Smoking Cessation
NCT02638597
Hypothermia and the Effect of Ambient Temperature
NCT02436382
Everolimus for Children With Recurrent or Progressive Ependymoma
NCT02155920
Negative Pressure Wound Therapy in Cesarean Section
NCT02289157
A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin
NCT02141906
UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
NCT02463500
Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
NCT02353806
Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
NCT02665117
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
NCT02312817
Lidocaine Infusion for Chronic Pain in Opioid Dependent Patients
NCT02219321
4D Cone Beam CT Reconstruction for Radiotherapy Via Motion Vector Optimization
NCT03551405
Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer
NCT02353832
Electrical Stimulation for Improving Balance in Diabetes
NCT02337218
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
NCT01966978
Primary Care, Communication, and Improving Children's Health
NCT02277899
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
NCT02201355
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
NCT02064712
IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis
NCT02241512
Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT)
NCT02308774
Reducing Type 2 Diabetes Diagnostic Delays Using Decision Support
NCT02199769
A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
NCT02138292
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic Syndrome
NCT02358928
Regional Manual Therapy and Motor Control Exercise for Chronic Low Back Pain
NCT02170753
Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis
NCT02165579
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
NCT02170181
Nifedipine for Acute Tocolysis of Preterm Labor
NCT02132533
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
NCT02064582
Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study
NCT02144935
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
NCT02411760
Psychosis and Affective Research Domains and Intermediate Phenotypes
NCT02218853
Icariin to Prevent Corticosteroid-related Memory Changes
NCT02112123
Citicoline for Alcohol Dependence
NCT02074735
A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients
NCT01984255
Impact of Walking Practice on Persons With PD
NCT02113189
Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer
NCT02045433
Metabolic Costs of Walking Post Stroke
NCT02108912
A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block
NCT02151487
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
NCT02388659
Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial
NCT02045446
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
NCT02082678
Gender Disparity and Hormones in Cystic Fibrosis
NCT02036879
Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
NCT01976169
A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
NCT02036281
TAP Block With Plain Bupivacaine Versus Wound Infiltration With Exparel for Postoperative Pain Management
NCT02074709
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
NCT02731521
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.